Results 71 to 80 of about 1,140,114 (148)

RETRACTION: HSP90 Inhibition Suppresses Inflammatory Response and Reduces Carotid Atherosclerotic Plaque Formation in ApoE Mice

Cardiovascular Therapeutics
Cardiovascular Therapeutics
doaj   +1 more source

Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND. [PDF]

Diabetes Care
Sattar N, Gerstein HC, D'Alessio D, Bhatt DL, Buse JB, Del Prato S, Kahn SE, Lincoff AM, McGuire DK, Nauck MA, Nissen SE, Zinman B, Zoungas S, Bartee A, Miller D, Nishiyama H, Qu Y, Weerakkody G, Wiese RJ, Pavo I, Nicholls SJ.   +20 more
europepmc   +1 more source

Therapeutics Letter 70

, 2008
Therapeutics Letter 70 summarizes the top five most accessed Cochrane reviews in 2007. Topics include prevention of fall in elderly people, treating obesity in children, low glycaemic diets for overweight and obesity, and nicotine receptor partial ...
Therapeutics Initiative (University of British Columbia)
core  

Small Nucleic Acid Therapeutics for Ocular Diseases: Progress, Challenges, and Future Perspectives. [PDF]

Pharmaceutics
Guo Q, Chen L, Wu Z, Zhang Q, Xue J, Zhang H.   +5 more
europepmc   +1 more source

Irreversible Electroporation for the Focal Treatment of Prostate Cancer: A Systematic Review

The World Journal of Men's Health
Purpose: Irreversible electroporation (IRE) is a promising alternative treatment for low-intermediate-risk localized prostate cancer. In this systematic review we aim to evaluate the safety profile and functional and oncological outcomes of this new ...
Kai Zhang, Jeremy Teoh, Gang Zhu, Chi-Fai Ng, Michel Suberville, Pilar Laguna, Jean de la Rosette   +6 more
doaj   +1 more source

Editorial: Translational research in the diagnosis and development of therapeutics for peritoneal surface malignancies

Frontiers in Oncology, 2023
Claramae Shulyn Chia, Claramae Shulyn Chia, Claramae Shulyn Chia, Claramae Shulyn Chia, Yan Li, Wim Ceelen, Chin-Ann Johnny Ong, Chin-Ann Johnny Ong, Chin-Ann Johnny Ong, Chin-Ann Johnny Ong, Chin-Ann Johnny Ong, Chin-Ann Johnny Ong   +11 more
doaj   +1 more source

Correction: Angiography- and IVUS-tip-detection-guided 3D wiring for CTO and non-CTO percutaneous coronary interventions. [PDF]

Cardiovasc Interv Ther
Okamura A, Yoshikawa R, Tanaka K, Suzuki S, Ishikawa M, Nagai H, Yamasaki T, Yamaji K, Kawamura K, Okamoto N, Ishihara T, Nagamatsu W, Serikawa T, Ito Y, Watanabe H.   +14 more
europepmc   +1 more source

Therapeutics Letter 118

, 2019
Therapeutics Letter 118 investigates trends in utilization of proton pump inhibitors in British Columbia, Canada. Conclusions PPI utilization in British Columbia has risen much faster than population growth.
Therapeutics Initiative (University of British Columbia)
core  

Late cytopenia after CD19 chimeric antigen receptor T-cell therapy in large B-cell lymphoma: a Cell Therapy Consortium analysis. [PDF]

Blood Adv
Wudhikarn K, Bromberg M, Brower J, Seshan V, Bachanova V, Ahmed S, McGuirk JP, Manu G, Maziarz RT, Oluwole OO, Schuster SJ, Porter DL, Bishop MR, Riedell PA, Perales MA, Dahi PB.   +15 more
europepmc   +1 more source

Therapeutics Letter 2

, 1994
Therapeutics Letter 2 discusses treatment of peptic ulcer disease by eradicating Helicobacter Pylori (H.pylori). H. pylori infection should be treated in patients with proven gastric or duodenal ulcers who are infected with H.
Therapeutics Initiative (University of British Columbia)
core